Diagnos Laboratorium Utama Tbk. vs Superkrane Mitra Utama Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Superkrane Mitra Utama Tbk. trades at Rp376 (market cap 2.93T, 390.2K 24h volume). The key difference: Superkrane Mitra Utama Tbk. is far larger — about 9.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 390.2K). Which is the better fit depends on your goals.
| DGNS | SKRN | |
|---|---|---|
Market Cap | 310.75B | 2.93T |
Volume | 963.6K | 390.2K |
Lot | 9.64K | 3.9K |
Turnover | 217.67M | 148.71M |
Average Price | 225.89 | 381.12 |
Value | 217.67M | 148.71M |
Indicative Equilibrium Price | 226 | 376 |
Indicative Equilibrium Volume | 1K | 123 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Superkrane Mitra Utama Tbk (the Company) was established based on Deed No. 285 by notary Ratna Komala Komar, S.H., dated March 27, 1996, in Jakarta.
Read more on SKRN →